iomeprol has been researched along with Hepatocellular Carcinoma in 20 studies
iomeprol: structure given in first source
iomeprol : A benzenedicarboxamide compound having N-substituted carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and a glycoloyl(methyl)amino group at the 5-position.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To investigate the volumetric iodine-uptake (VIU) changes by dual-energy CT (DECT) in assessing the response to sorafenib treated hepatocellular carcinoma (HCC) patients, compared with AASLD (American Association for the Study of Liver Diseases) and Choi criteria." | 9.17 | Quantitative therapy response assessment by volumetric iodine-uptake measurement: initial experience in patients with advanced hepatocellular carcinoma treated with sorafenib. ( Dai, X; Ganten, MK; Ganten, TM; Höh, K; Schlemmer, HP; Schmidt, B; Xu, K, 2013) |
| "1 and modified RECIST (mRECIST) in patients with unresectable hepatocellular carcinoma (HCC) on sorafenib, and to describe HCC enhancement changes before and after sorafenib treatment." | 7.80 | Hepatocellular carcinoma enhancement on contrast-enhanced CT and MR imaging: response assessment after treatment with sorafenib: preliminary results. ( Agnello, F; Brancatelli, G; Cabibbo, G; Furlan, A; Genco, C; Giannitrapani, L; Lagalla, R; Marin, D; Midiri, M; Salvaggio, G, 2014) |
| "To investigate the volumetric iodine-uptake (VIU) changes by dual-energy CT (DECT) in assessing the response to sorafenib treated hepatocellular carcinoma (HCC) patients, compared with AASLD (American Association for the Study of Liver Diseases) and Choi criteria." | 5.17 | Quantitative therapy response assessment by volumetric iodine-uptake measurement: initial experience in patients with advanced hepatocellular carcinoma treated with sorafenib. ( Dai, X; Ganten, MK; Ganten, TM; Höh, K; Schlemmer, HP; Schmidt, B; Xu, K, 2013) |
| "1 and modified RECIST (mRECIST) in patients with unresectable hepatocellular carcinoma (HCC) on sorafenib, and to describe HCC enhancement changes before and after sorafenib treatment." | 3.80 | Hepatocellular carcinoma enhancement on contrast-enhanced CT and MR imaging: response assessment after treatment with sorafenib: preliminary results. ( Agnello, F; Brancatelli, G; Cabibbo, G; Furlan, A; Genco, C; Giannitrapani, L; Lagalla, R; Marin, D; Midiri, M; Salvaggio, G, 2014) |
| "To define the percentage of small (≤2 cm) hepatocellular carcinoma (HCC) nodules showing the diagnostic enhancement pattern at CEUS, computed tomography (CT), and gadobenate dimeglumine (Gd-BOPTA)-enhanced magnetic resonance (MR) imaging." | 3.79 | Evidence of diagnostic enhancement pattern in hepatocellular carcinoma nodules ≤2 cm according to the AASLD/EASL revised criteria. ( Angileri, R; Cabibbo, B; Cova, MA; De Paoli, L; Pizzolato, R; Quaia, E, 2013) |
| "We evaluated iomeprol-containing liposomes (Lipiom), a new contrast medium for computed tomography (CT) liver scanning, in an animal model of chemically induced hepatocellular carcinomas and other liver tumors in rats." | 3.69 | Enhancement of computed tomography liver contrast using iomeprol-containing liposomes and detection of small liver tumors in rats. ( Burkhardt, S; Fouillet, X; Khan, H; Sabitha, S; Schneider, M; Terrier, F; Tournier, H, 1995) |
| "Spontaneous rupture of hepatocellular carcinoma (HCC) after transcatheter arterial chemoembolization (TACE) is a rare and life-threatening complication." | 1.38 | Spontaneous liver rupture after treatment with drug-eluting beads. ( Goltz, JP; Hahn, D; Kickuth, R; Mottok, A; Ritter, CO; Steger, U; Wartenberg, M, 2012) |
| "C-arm CT helps detection of hepatocellular carcinoma (HCC) during interventional (TACE) treatment." | 1.38 | Diagnostic accuracy of C-arm CT during selective transcatheter angiography for hepatocellular carcinoma: comparison with intravenous contrast-enhanced, biphasic, dynamic MDCT. ( Higashihara, H; Hori, M; Kim, T; Maeda, N; Nakamoto, A; Onishi, H; Osuga, K; Tomiyama, N; Tsuboyama, T, 2012) |
| "During the arterial phase the residual tumor appeared hyperdense in 97% of the nodules and isodense in 3%, while during the portal phase it was hyperdense in 22%, isodense in 28% and hypodense in 50%, and during the delayed phase hypodense in 100%." | 1.30 | [Multiphasic spiral computed tomography in hepatocarcinoma. An evaluation following different percutaneous ablative procedures]. ( Altei, F; Catalano, O; Cusati, B; Esposito, M; Lobianco, R; Siani, A, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (15.00) | 18.2507 |
| 2000's | 3 (15.00) | 29.6817 |
| 2010's | 14 (70.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Masada, T | 1 |
| Tanaka, T | 1 |
| Nishiofuku, H | 1 |
| Fukuoka, Y | 1 |
| Sato, T | 1 |
| Tatsumoto, S | 1 |
| Marugami, N | 1 |
| Kichikawa, K | 1 |
| Mulé, S | 1 |
| Pigneur, F | 1 |
| Quelever, R | 1 |
| Tenenhaus, A | 1 |
| Baranes, L | 1 |
| Richard, P | 1 |
| Tacher, V | 1 |
| Herin, E | 1 |
| Pasquier, H | 1 |
| Ronot, M | 1 |
| Rahmouni, A | 1 |
| Vilgrain, V | 1 |
| Luciani, A | 1 |
| Quaia, E | 1 |
| De Paoli, L | 1 |
| Angileri, R | 1 |
| Pizzolato, R | 1 |
| Cabibbo, B | 1 |
| Cova, MA | 1 |
| Salvaggio, G | 1 |
| Furlan, A | 2 |
| Agnello, F | 1 |
| Cabibbo, G | 1 |
| Marin, D | 1 |
| Giannitrapani, L | 1 |
| Genco, C | 1 |
| Midiri, M | 2 |
| Lagalla, R | 2 |
| Brancatelli, G | 1 |
| Bartolotta, TV | 1 |
| Taibbi, A | 1 |
| Matranga, D | 1 |
| Lewin, M | 1 |
| Gelu-Simeon, M | 1 |
| Ostos, M | 1 |
| Boufassa, F | 1 |
| Sobesky, R | 1 |
| Teicher, E | 1 |
| Meyer, L | 1 |
| Fontaine, H | 1 |
| Salmon-Céron, D | 1 |
| Samuel, D | 1 |
| Seror, O | 1 |
| Trinchet, JC | 1 |
| Duclos-Vallée, JC | 1 |
| Anzidei, M | 1 |
| Di Martino, M | 1 |
| Sacconi, B | 1 |
| Saba, L | 1 |
| Boni, F | 1 |
| Zaccagna, F | 1 |
| Geiger, D | 1 |
| Kirchin, MA | 1 |
| Napoli, A | 1 |
| Bezzi, M | 1 |
| Catalano, C | 1 |
| Saake, M | 1 |
| Lell, MM | 1 |
| Eller, A | 1 |
| Wuest, W | 1 |
| Heinz, M | 1 |
| Uder, M | 1 |
| Schmid, A | 1 |
| Kloeckner, R | 1 |
| Otto, G | 2 |
| Biesterfeld, S | 1 |
| Oberholzer, K | 1 |
| Dueber, C | 1 |
| Pitton, MB | 2 |
| Miyayama, S | 1 |
| Yamashiro, M | 1 |
| Okuda, M | 1 |
| Yoshie, Y | 1 |
| Nakashima, Y | 1 |
| Ikeno, H | 1 |
| Orito, N | 1 |
| Matsui, O | 1 |
| Ritter, CO | 1 |
| Wartenberg, M | 1 |
| Mottok, A | 1 |
| Steger, U | 1 |
| Goltz, JP | 1 |
| Hahn, D | 1 |
| Kickuth, R | 1 |
| Kawamura, Y | 1 |
| Ikeda, K | 1 |
| Seko, Y | 1 |
| Hosaka, T | 1 |
| Kobayashi, M | 1 |
| Saitoh, S | 1 |
| Kumada, H | 1 |
| Higashihara, H | 1 |
| Osuga, K | 1 |
| Onishi, H | 1 |
| Nakamoto, A | 1 |
| Tsuboyama, T | 1 |
| Maeda, N | 1 |
| Hori, M | 1 |
| Kim, T | 1 |
| Tomiyama, N | 1 |
| Dai, X | 1 |
| Schlemmer, HP | 1 |
| Schmidt, B | 1 |
| Höh, K | 1 |
| Xu, K | 1 |
| Ganten, TM | 1 |
| Ganten, MK | 1 |
| Pozzi Mucelli, RM | 1 |
| Como, G | 1 |
| Del Frate, C | 1 |
| Iuri, D | 1 |
| Al-Grhiw, E | 1 |
| Bazzocchi, M | 1 |
| Herber, SC | 1 |
| Schneider, J | 1 |
| Schuchmann, M | 1 |
| Düber, C | 1 |
| Kummer, I | 1 |
| Manzl, N | 1 |
| Fouillet, X | 1 |
| Tournier, H | 1 |
| Khan, H | 1 |
| Sabitha, S | 1 |
| Burkhardt, S | 1 |
| Terrier, F | 1 |
| Schneider, M | 1 |
| Ishijima, H | 1 |
| Koyama, Y | 1 |
| Aoki, J | 1 |
| Kawano, T | 1 |
| Nakajima, T | 1 |
| Ishizaka, H | 1 |
| Endo, K | 1 |
| Cho, A | 1 |
| Okazumi, S | 1 |
| Takayama, W | 1 |
| Takeda, A | 1 |
| Iwasaki, K | 1 |
| Sasagawa, S | 1 |
| Natsume, T | 1 |
| Kono, T | 1 |
| Kondo, S | 1 |
| Ochiai, T | 1 |
| Ryu, M | 1 |
| Catalano, O | 1 |
| Esposito, M | 1 |
| Lobianco, R | 1 |
| Cusati, B | 1 |
| Altei, F | 1 |
| Siani, A | 1 |
1 trial available for iomeprol and Hepatocellular Carcinoma
| Article | Year |
|---|---|
Quantitative therapy response assessment by volumetric iodine-uptake measurement: initial experience in patients with advanced hepatocellular carcinoma treated with sorafenib.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Hepatocellular; Contrast Media; Female; H | 2013 |
19 other studies available for iomeprol and Hepatocellular Carcinoma
| Article | Year |
|---|---|
Techniques to Form a Suitable Lipiodol-Epirubicin Emulsion by Using 3-Way Stopcock Methods in Transarterial Chemoembolization for Liver Tumor.
Topics: Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Contrast Med | 2017 |
Can dual-energy CT replace perfusion CT for the functional evaluation of advanced hepatocellular carcinoma?
Topics: Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Contrast Media; Female; Humans; Iodine; Iopamido | 2018 |
Evidence of diagnostic enhancement pattern in hepatocellular carcinoma nodules ≤2 cm according to the AASLD/EASL revised criteria.
Topics: Aged; Biopsy; Carcinoma, Hepatocellular; Contrast Media; Diagnosis, Differential; Female; Humans; Im | 2013 |
Hepatocellular carcinoma enhancement on contrast-enhanced CT and MR imaging: response assessment after treatment with sorafenib: preliminary results.
Topics: Aged; Carcinoma, Hepatocellular; Contrast Media; Female; Humans; Iopamidol; Liver Neoplasms; Magneti | 2014 |
3D versus 2D contrast-enhanced sonography in the evaluation of therapeutic response of hepatocellular carcinoma after locoregional therapies: preliminary findings.
Topics: Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Contrast Media; Female; Humans; Image Interpreta | 2015 |
Imaging Features and Prognosis of Hepatocellular Carcinoma in Patients with Cirrhosis Who Are Coinfected with Human Immunodeficiency Virus and Hepatitis C Virus.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Coinfection; Contrast Media; Diagnostic Imaging; Female; Fra | 2015 |
Evaluation of image quality, radiation dose and diagnostic performance of dual-energy CT datasets in patients with hepatocellular carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Contrast Media; Female; Humans; Imaging, | 2015 |
Imaging Hepatocellular Carcinoma with Dynamic CT Before and After Transarterial Chemoembolization: Optimal Scan Timing of Arterial Phase.
Topics: Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Contrast Media; | 2015 |
MDCT versus MRI assessment of tumor response after transarterial chemoembolization for the treatment of hepatocellular carcinoma.
Topics: Aged; Antimetabolites, Antineoplastic; Artifacts; Carcinoma, Hepatocellular; Chemoembolization, Ther | 2010 |
Detection of corona enhancement of hypervascular hepatocellular carcinoma by C-arm dual-phase cone-beam CT during hepatic arteriography.
Topics: Aged, 80 and over; Angiography; Carcinoma, Hepatocellular; Cone-Beam Computed Tomography; Contrast M | 2011 |
Spontaneous liver rupture after treatment with drug-eluting beads.
Topics: Aged; Angiography; Carcinoma, Hepatocellular; Contrast Media; Doxorubicin; Fatal Outcome; Humans; Io | 2012 |
Heterogeneous type 4 enhancement of hepatocellular carcinoma on dynamic CT is associated with tumor recurrence after radiofrequency ablation.
Topics: Carcinoma, Hepatocellular; Catheter Ablation; Contrast Media; Female; Humans; Iopamidol; Liver Neopl | 2011 |
Diagnostic accuracy of C-arm CT during selective transcatheter angiography for hepatocellular carcinoma: comparison with intravenous contrast-enhanced, biphasic, dynamic MDCT.
Topics: Aged; Aged, 80 and over; Angiography; Carcinoma, Hepatocellular; Catheterization; Contrast Media; Eq | 2012 |
Multidetector CT with double arterial phase and high-iodine-concentration contrast agent in the detection of hepatocellular carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Contrast Media; Female; Follow-Up Studies | 2006 |
Transarterial chemoembolization in patients not eligible for liver transplantation: single-center results.
Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Chemoemboliz | 2008 |
Enhancement of computed tomography liver contrast using iomeprol-containing liposomes and detection of small liver tumors in rats.
Topics: Animals; Carcinoma, Hepatocellular; Contrast Media; Disease Models, Animal; Dose-Response Relationsh | 1995 |
Use of a combined CT-angiography system for demonstration of correlative anatomy during embolotherapy for hepatocellular carcinoma.
Topics: Aged; Aged, 80 and over; Angiography; Angiography, Digital Subtraction; Antibiotics, Antineoplastic; | 1999 |
Anatomy of the right anterosuperior area (segment 8) of the liver: evaluation with helical CT during arterial portography.
Topics: Adult; Aged; Bile Duct Neoplasms; Carcinoma, Hepatocellular; Contrast Media; Female; Gallbladder Neo | 2000 |
[Multiphasic spiral computed tomography in hepatocarcinoma. An evaluation following different percutaneous ablative procedures].
Topics: Adult; Aged; Carcinoma, Hepatocellular; Catheter Ablation; Chemoembolization, Therapeutic; Combined | 1999 |